Floatz logo

Estriol

Neurogenic Bladder

Texas Tech University Health Sciences CenterSmall moleculePhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Neurogenic Bladder cohort.

Asset / SponsorPhaseRating
Oxybutynin
Astellas Pharma Inc
Phase 4BB
SOLIFENACIN
Astellas Pharma Inc
Phase 4B
Uro Vaxom
Buckinghamshire Healthcare NHS Trust
Phase 2B
ROSEMARY
University of Oran 1
N/AD
LAVENDER OIL
University of Oran 1
N/AD

Same molecule, other indications

Estriol is also rated in:

postmenopausal atrophic vaginitisDormant
BB
Indicative ·
64 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
B
Indicative ·
57 / 100
View asset →
secondary progressive multiple sclerosisDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →